D VİTAMİNİ İLE KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI İLİŞKİSİ

Mahir Arslan

doi:10.25279/sak.423115

D VİTAMİNİ İLE KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI İLİŞKİSİ

Öz

İnsanlarda D vitamini ihtiyacının %95 kadarı güneş ışınlarının etkisiyle deride sentezlenmektedir. Mevsimler, günün saati, cam, deri koruyucular, geleneksel giyim tarzı, yaşlanma, yaşanılan enlem bölgesi ve pigmentasyon derideki bu dönüşümü etkiler. Vitamin D eksikliği osteoporoz ve erişkinlerde kemiğin diğer bir hastalığı osteomalazi, çocuklarda raşitizme neden olur. Vitamin D eksikliği ayrıca kardiyovasküler hastalık, metabolik sendrom, solunum yolu hastalıkları ve kanserin yanında multipl skleroz, romatoid artrit, tip 1 diyabet gibi birçok otoimmün sistem hastalığın görülme riskini artırır. Bu derlemede D vitamini ve kronik obstrüktif akciğer hastalığı arasındaki ilişki ele alınmıştır.

Anahtar Kelimeler

D vitamini,Nonskeletal Etki,Kronik Obstrüktif Akciğer Hastalığı

Kaynakça

(IOM) Institute of Medicine. (2011). Dietary Reference Intakes for Calcium and Vitamin D. Washington DC: The National Academies Press.
Adams, J. S., & Hewison, M. (2010). Update in vitamin D. J Clin Endocrinol Metab, 95(2), 471-478.
Akpınar, E. E. (2011). Kronik obstrüktif akciğer hastalığının sistemik etkileri. Solunum Hastalıkları, 22, 107-114.
Aranow, C. (2011). Vitamin D and the immune system. J Investig Med, 59(6), 881-886.
Baeke, F., Takiishi, T., Korf, H., Gysemans, C., & Mathieu, C. (2010). Vitamin D: modulator of the immune system. Curr Opin Pharmacol, 10(4), 482-496.
Baeke, F., van Etten, E., Gysemans, C., Overbergh, L., & Mathieu, C. (2008). Vitamin D signaling in immune-mediated disorders: Evolving insights and therapeutic opportunities. Mol Aspects Med, 29(6), 376-387.
Bals, R., Wang, X., Zasloff, M., & Wilson, J. M. (2008). The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A, 95(16), 9541-9546.
Barnes, P. J., & Celli, B. R. (2009). Systemic manifestations and comorbidities of COPD. Eur Respir J, 33(5), 1165-1185.

Barreiro, E., Fermoselle, C., Mateu-Jimenez, M., Sanchez-Font, A., Pijuan, L., Gea, J., & Curull, V. (2013). Oxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPD. Free Radic Biol Med, 65, 859-871.
Black, P. N., & Scragg, R. (2005). Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest, 128(6), 3792-3798.
Bouillon, R. (2011). The Vitamin D Binding Protein DBP. In J. Adams, D. Feldman, & J. W. Pike (Eds.), Vitamin D (Third Edition) (pp. 57-72). San Diego: Academic Press.
Bourjeily, G., & Rochester, C. L. (2000). Exercise training in chronic obstructive pulmonary disease. Clin Chest Med, 21(4), 763-781.
Boyan, B. D., Wong, K. L., Fang, M., & Schwartz, Z. (2007). 1alpha,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases. J Steroid Biochem Mol Biol, 103(3-5), 467-472.
Bozinovski, S., Anthony, D., & Vlahos, R. (2014). Targeting pro-resolution pathways to combat chronic inflammation in COPD. J Thorac Dis, 6(11), 1548-1556.
Brusselle, G. G., Joos, G. F., & Bracke, K. R. (2011). New insights into the immunology of chronic obstructive pulmonary disease. Lancet, 378(9795), 1015-1026.
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B., Jensen, R. L., Marks, G. B., Gulsvik, A., Nizankowska-Mogilnicka, E., & Group, B. C. R. (2007). International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet, 370(9589), 741-750.
Choi, C.-J., Seo, M., Choi, W.-S., Kim, K.-S., Youn, S.-A., Lindsey, T., Choi, Y.-J., & Kim, C.-M. (2013). Relationship between serum 25-hydroxyvitamin D and lung function among Korean adults in Korea National Health and Nutrition Examination Survey (KNHANES), 2008–2010. The Journal of Clinical Endocrinology & Metabolism, 98(4), 1703-1710.
Christakos, S., Hewison, M., Gardner, D. G., Wagner, C. L., Sergeev, I. N., Rutten, E., Pittas, A. G., Boland, R., Ferrucci, L., & Bikle, D. D. (2013). Vitamin D: beyond bone. Ann N Y Acad Sci, 1287, 45-58.
Damera, G., Fogle, H. W., Lim, P., Goncharova, E. A., Zhao, H., Banerjee, A., Tliba, O., Krymskaya, V. P., & Panettieri, R. A., Jr. (2009). Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1. Br J Pharmacol, 158(6), 1429-1441.
Deluca, H. F. (2014). History of the discovery of vitamin D and its active metabolites. Bonekey Rep, 3, 479.
Dursunoglu, N., Kokturk, N., Baha, A., Bilge, A. K., Borekci, S., Ciftci, F., Gezmen Karadag, M., Calik Kutukcu, E., Noyan, A., Polatli, M., Onen, Z. P., Sarinc, S., Umut, S., Uzaslan, E., Kubat Uzum, A., & Akkoca Yildiz, O. (2016). Comorbidities and their impact on chronic obstructive pulmonary disease. Tuberk Toraks, 64(4), 289-298.
Franco, C. B., Paz-Filho, G., Gomes, P. E., Nascimento, V. B., Kulak, C. A., Boguszewski, C. L., & Borba, V. Z. (2009). Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int, 20(11), 1881-1887.
GOLD. (2018). Global Strategy for Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease 2018 Report. Retrieved from http://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf
Gosselink, R., Troosters, T., & Decramer, M. (2010). Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med, 153(3), 152-155.
Graat-Verboom, L., van den Borne, B. E., Smeenk, F. W., Spruit, M. A., & Wouters, E. F. (2011). Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J Bone Miner Res, 26(3), 561-568.
Grant, W. B., & Holick, M. F. (2005). Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev, 10(2), 94-111.
Grober, U., Spitz, J., Reichrath, J., Kisters, K., & Holick, M. F. (2013). Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcare. Dermatoendocrinol, 5(3), 331-347.
Hernigou, P., Auregan, J. C., & Dubory, A. (2018). Vitamin D: part I; from plankton and calcified skeletons (500 million years ago) to rickets. Int Orthop.
Herr, C., Greulich, T., Koczulla, R. A., Meyer, S., Zakharkina, T., Branscheidt, M., Eschmann, R., & Bals, R. (2011). The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res, 12, 31.
Holick, M. F. (2007). Vitamin D deficiency. N Engl J Med, 357(3), 266-281.
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011). Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 96(7), 1911-1930.
Hopkinson, N. S., Li, K. W., Kehoe, A., Humphries, S. E., Roughton, M., Moxham, J., Montgomery, H., & Polkey, M. I. (2008). Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr, 87(2), 385-390.
Horasan, G. D. (2013). Kronik Solunum Yolu Hastalıkları. In B. Ünal & G. Ergör (Eds.), Türkiye Kronik Hastalıklar ve Risk Faktörleri Sıklığı Çalışması Final Raporu (pp. 207-220). Ankara: Anıl Matbaa.
Hornikx, M., Van Remoortel, H., Lehouck, A., Mathieu, C., Maes, K., Gayan-Ramirez, G., Decramer, M., Troosters, T., & Janssens, W. (2012). Vitamin D supplementation during rehabilitation in COPD: a secondary analysis of a randomized trial. Respir Res, 13, 84.
Janssens, W., Bouillon, R., Claes, B., Carremans, C., Lehouck, A., Buysschaert, I., Coolen, J., Mathieu, C., Decramer, M., & Lambrechts, D. (2010). Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax, 65(3), 215-220.
Kocabas, A., Hancioglu, A., Turkyilmaz, S., & Arslan, M. (2006). Prevalence of COPD in Adana, Turkey (BOLD-Turkey Study). Proc Am Thorac Soc, 3, A543.
Kulie, T., Groff, A., Redmer, J., Hounshell, J., & Schrager, S. (2009). Vitamin D: an evidence-based review. J Am Board Fam Med, 22(6), 698-706.
Kunisaki, K. M., Niewoehner, D. E., Singh, R. J., & Connett, J. E. (2012). Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur Respir J, 37(2), 238-243.
Lehouck, A., Mathieu, C., Carremans, C., Baeke, F., Verhaegen, J., Van Eldere, J., Decallonne, B., Bouillon, R., Decramer, M., & Janssens, W. (2012). High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med, 156(2), 105-114.
Litwack, G. (2008). Human Biochemistry and Disease. Amsterdam: Elsevier.
López‐Campos, J. L., Tan, W., & Soriano, J. B. (2016). Global burden of COPD. Respirology, 21(1), 14-23.
Loukides, S., Bartziokas, K., Vestbo, J., & Singh, D. (2013). Novel anti-inflammatory agents in COPD: targeting lung and systemic inflammation. Curr Drug Targets, 14(2), 235-245.
Masala, S., Magrini, A., Taglieri, A., Nano, G., Chiaravalloti, A., Calabria, E., Di Trapano, R., Pietroiusti, A., & Simonetti, G. (2014). Chronic obstructive pulmonary disease (COPD) patients with osteoporotic vertebral compression fractures (OVCFs): improvement of pulmonary function after percutaneous vertebroplasty (VTP). Eur Radiol, 24(7), 1577-1585.
McLendon, K., & Gossman, W. G. (2018). EMS, Field Identification Of Chronic Obstructive Pulmonary Disease (COPD) StatPearls. Treasure Island (FL): StatPearls Publishing LLC.
Mohr, S. B. (2009). A brief history of vitamin d and cancer prevention. Ann Epidemiol, 19(2), 79-83.
Nuti, R., Siviero, P., Maggi, S., Guglielmi, G., Caffarelli, C., Crepaldi, G., & Gonnelli, S. (2009). Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study. Osteoporos Int, 20(6), 989-998.
Özkan, B., & Döneray, H. (2011). D vitamininin iskelet sistemi dışı etkileri. Çocuk Sağlığı ve Hastalıkları Dergisi, 54, 99-119.
Peter, W. J., Whitfield, G. K., Ryan, F., Shane, B., Jamie, L., & Mark, R. H. (2012). Vitamin D Vitamin D (pp. 3-36): CRC Press.
Pilz, S., Trummer, C., Pandis, M., Schwetz, V., Aberer, F., Grubler, M., Verheyen, N., Tomaschitz, A., & Marz, W. (2018). Vitamin D: Current Guidelines and Future Outlook. Anticancer Res, 38(2), 1145-1151. doi:10.21873/anticanres.12333
Pludowski, P., Holick, M. F., Pilz, S., Wagner, C. L., Hollis, B. W., Grant, W. B., Shoenfeld, Y., Lerchbaum, E., Llewellyn, D. J., Kienreich, K., & Soni, M. (2013). Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality—A review of recent evidence. Autoimmunity Reviews, 12(10), 976-989.
Pramyothin, P., & Holick, M. F. (2012). Vitamin D supplementation: guidelines and evidence for subclinical deficiency. Curr Opin Gastroenterol, 28(2), 139-150.
Rajakumar, K. (2003). Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics, 112(2), e132-135.
Ringbaek, T., Martinez, G., Durakovic, A., Thogersen, J., Midjord, A. K., Jensen, J. E., & Lange, P. (2011). Vitamin d status in patients with chronic obstructive pulmonary disease who participate in pulmonary rehabilitation. J Cardiopulm Rehabil Prev, 31(4), 261-267.
Semba, R. D., Chang, S. S., Sun, K., Cappola, A. R., Ferrucci, L., & Fried, L. P. (2012). Serum 25-Hydroxyvitamin D and Pulmonary Function in Older Disabled Community-Dwelling Women. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 67A(6), 683-689.
Shaheen, S. O., Jameson, K. A., Robinson, S. M., Boucher, B. J., Syddall, H. E., Sayer, A. A., Cooper, C., Holloway, J. W., & Dennison, E. M. (2011). Relationship of vitamin D status to adult lung function and COPD. Thorax, thx. 2010.155234.
Sözen, T. (2011). D hormonu: Güncel gelişmeler. Hacettepe Tıp Dergisi, 42, 14-27.
Tellioğlu, A., & Başaran, S. (2013). Güncel Bilgiler Işığında Vitamin D. Arşiv Kaynak Tarama Dergisi, 22(2), 259-271.
Uzun, K., & Maden, E. (2013). KOAH’da sistemik sorunlar ve yaklaşım. Güncel Göğüs Hastalıkları Serisi, 1, 153-160.
Visweswaran, R. K., & Lekha, H. (2013). Extraskeletal effects and manifestations of Vitamin D deficiency. Indian J Endocrinol Metab, 17(4), 602-610.
Wacker, M., & Holick, M. F. (2013). Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol, 5(1), 51-108.
Wen, H., & Baker, J. F. (2011). Vitamin D, immunoregulation, and rheumatoid arthritis. J Clin Rheumatol, 17(2), 102-107.
White, J. H. (2012). Vitamin D metabolism and signaling in the immune system. Rev Endocr Metab Disord, 13(1), 21-29.
WHO. (2018). Chronic obstructive pulmonary disease (COPD). Retrieved from http://www.who.int/respiratory/copd/en/
Wimalawansa, S. J., Razzaque, M. S., & Al-Daghri, N. M. (2017). Calcium and vitamin D in human health: Hype or real? J Steroid Biochem Mol Biol.
Wolf, G. (2004). The discovery of vitamin D: the contribution of Adolf Windaus. J Nutr, 134(6), 1299-1302.
Zhang, L. L., Gong, J., & Liu, C. T. (2014). Vitamin D with asthma and COPD: not a false hope? A systematic review and meta-analysis. Genet Mol Res, 13(3), 7607-7616.
Zhou, H., Wu, Y., Jin, Y., Zhou, J., Zhang, C., Che, L., Jing, J., Chen, Z., Li, W., & Shen, H. (2013). Genetic polymorphism of matrix metalloproteinase family and chronic obstructive pulmonary disease susceptibility: a meta-analysis. Sci Rep, 3, 2818.

Ayrıntılar

Birincil Dil

Türkçe

Konular

Beslenme ve Diyetetik

Bölüm

Derleme

Yazarlar

Mahir Arslan ^*
Türkiye

Yayımlanma Tarihi

1 Nisan 2020

Gönderilme Tarihi

12 Mayıs 2018

Kabul Tarihi

9 Ekim 2018

Yayımlandığı Sayı

Yıl 2020 Cilt: 5 Sayı: 1

DOI

https://doi.org/10.25279/sak.423115

IZ

https://izlik.org/JA36TH86BU

Kaynak Göster

RIS / Bibtex

APA

Arslan, M. (2020). D VİTAMİNİ İLE KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI İLİŞKİSİ. Health Academy Kastamonu, 5(1), 65-77. https://doi.org/10.25279/sak.423115

AMA

1.Arslan M. D VİTAMİNİ İLE KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI İLİŞKİSİ. sak. 2020;5(1):65-77. doi:10.25279/sak.423115

Chicago

Arslan, Mahir. 2020. “D VİTAMİNİ İLE KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI İLİŞKİSİ”. Health Academy Kastamonu 5 (1): 65-77. https://doi.org/10.25279/sak.423115.

EndNote

Arslan M (01 Nisan 2020) D VİTAMİNİ İLE KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI İLİŞKİSİ. Health Academy Kastamonu 5 1 65–77.

IEEE

[1]M. Arslan, “D VİTAMİNİ İLE KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI İLİŞKİSİ”, sak, c. 5, sy 1, ss. 65–77, Nis. 2020, doi: 10.25279/sak.423115.

ISNAD

Arslan, Mahir. “D VİTAMİNİ İLE KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI İLİŞKİSİ”. Health Academy Kastamonu 5/1 (01 Nisan 2020): 65-77. https://doi.org/10.25279/sak.423115.

JAMA

1.Arslan M. D VİTAMİNİ İLE KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI İLİŞKİSİ. sak. 2020;5:65–77.

MLA

Arslan, Mahir. “D VİTAMİNİ İLE KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI İLİŞKİSİ”. Health Academy Kastamonu, c. 5, sy 1, Nisan 2020, ss. 65-77, doi:10.25279/sak.423115.

Vancouver

1.Mahir Arslan. D VİTAMİNİ İLE KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI İLİŞKİSİ. sak. 01 Nisan 2020;5(1):65-77. doi:10.25279/sak.423115

Cited By

Covid-19 Pandemisi: Karantina İçin Beslenme Önerileri

Anadolu Kliniği Tıp Bilimleri Dergisi

https://doi.org/10.21673/anadoluklin.722546

Kronik Obstrüktif Akciğer Hastalığı Olan Malnütrisyonlu Bireylerde Hemşirelik Yaklaşımı

Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi

https://doi.org/10.46483/deuhfed.931900